CANBRIDGE PHARMACEUTICALS
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.
CANBRIDGE PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.canbridgepharma.com
Total Employee:
101+
Status:
Active
Contact:
(108) 414-8018
Total Funding:
224.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Domain Not Resolving Global Site Tag Microsoft Exchange Online Office 365 Mail
Similar Organizations
Ascent Health & Wellness Solutions
Ascent is a pharma supply-chain company focussed at improving the accessibility to and affordability of effective healthcare.
Current Advisors List
Board_member
2020-05-01
Board_member
Current Employees Featured
James Xue Chairman, President & CEO @ CANbridge Pharmaceuticals
Chairman, President & CEO
2012-06-01
Gerald Cox Chief Development Strategist & Interim CMO @ CANbridge Pharmaceuticals
Chief Development Strategist & Interim CMO
Richard J. Gregory Chief Scientific Officer @ CANbridge Pharmaceuticals
Chief Scientific Officer
2020-01-01
Glenn Hassan CFO & CBO @ CANbridge Pharmaceuticals
CFO & CBO
Pauline Li SVP of Clinical Development and Operations @ CANbridge Pharmaceuticals
SVP of Clinical Development and Operations
2022-05-01
Founder
Stock Details
Investors List
Hangzhou Zhiyan Dongli Jishu Management Consulting
Hangzhou Zhiyan Dongli Jishu Management Consulting investment in Series E - CANbridge Pharmaceuticals
Hudson Bay Capital Management
Hudson Bay Capital Management investment in Series E - CANbridge Pharmaceuticals
3W Partners
3W Partners investment in Series E - CANbridge Pharmaceuticals
Casdin Capital
Casdin Capital investment in Series E - CANbridge Pharmaceuticals
LYFE Capital
LYFE Capital investment in Series E - CANbridge Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series E - CANbridge Pharmaceuticals
SPDB International Holdings
SPDB International Holdings investment in Series E - CANbridge Pharmaceuticals
Bulldog Innovation Group LLC
Bulldog Innovation Group LLC investment in Series E - CANbridge Pharmaceuticals
Summer Capital
Summer Capital investment in Series E - CANbridge Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series D - CANbridge Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.canbridgepharma.com Semrush global rank: 857.66 K Semrush visits lastest month: 44.08 K
- Host name: 42.159.132.179
- IP address: 42.159.132.179
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
More informations about "CANbridge Pharmaceuticals"
Home | CANbridge
Established in 2012, CANbridge is a leading China-based, global rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies.See details»
CANbridge Pharmaceuticals Inc. - LinkedIn
CANbridge Pharmaceuticals Inc. | 2,916 followers on LinkedIn. To be a global biopharmaceutical company delivering life-changing therapeutics built upon a foundation in China. | CANbridge ...See details»
CANbridge Pharmaceuticals - Crunchbase Company Profile
Contact Email info@canbridgepharma.com Phone Number (108) 414-8018 CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and …See details»
Canbridge Pharmaceuticals Org Chart + Executive Team - The …
The organizational chart of Canbridge Pharmaceuticals displays its 27 main executives including James Xue, Qian Ma and Will WangSee details»
CANbridge Pharmaceuticals Inc. Information - RocketReach
CANbridge Pharmaceuticals Inc. is a China-focused biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and …See details»
Investors | CANbridge
CANbridge Pharmaceuticals Inc. (HKEX:1228) is a global biopharmaceutical company, with a foundation in China, committed to the research, development and commercialization of …See details»
CANbridge Pharmaceuticals - Org Chart, Teams, Culture & Jobs
View CANbridge Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
CANbridge Pharmaceuticals Company Description - Stock Analysis
4 days ago Ticker Symbol: 1228: Exchange: Hong Kong Stock Exchange: Fiscal Year: January - December: Reporting Currency: CNY: ISIN Number: KYG8587E1061: SIC Code: 2836See details»
CANbridge Pharmaceuticals Company Profile | Management and …
Www.canbridgepharma.com CANbridge Pharmaceuticals Profile and History CANbridge Pharmaceuticals Inc. (HKEX:1228) is a China and US-based global biopharmaceutical …See details»
Canbridge Pharmaceuticals - Overview, News & Similar
Jul 4, 2022 CANbridge Announces Full Enrollment Reached in the Core Part of The CAN103 Phase 2 Trial for Gaucher Disease in China BEIJING and BURLINGTON, Mass., Oct. 16, …See details»
CANbridge Pharmaceuticals | Life Sciences | Pharmaceuticals
Established in 2012, CANbridge is a leading China-based, global rare disease-focused biopharmaceutical company committed to the research, development and commercialization …See details»
CANbridge Pharmaceuticals Inc. ’s Post - LinkedIn
James Xue - Founder, Chairman & CEO, CANbridge Pharmaceuticals https://pharmaboardroom.comSee details»
CANbridge Pharmaceuticals Inc. Company Overview, Contact …
Feb 1, 2020 Canbridgepharma hired Edward Hu as non-executive director of the Board of Directors and member of the Remuneration Committee on Jul 5th '22. CANbridge …See details»
CANbridge Pharmaceuticals
•21 years of biotechnology executive management experience • Former CMO at EditasMedicine and VP at Genzyme • Made major contributions to 4 INDs and 3 orphan drug marketing …See details»
Canbridge Pharmaceuticals, Inc. (United States) (Canbridge ...
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- CANbridge Pharmaceuticals, Inc. (1228.HK), a China and U.S.-based global biopharmaceutical company committed to the …See details»
CANbridge Life Sciences Ltd.
了解CANbridge Life Sciences Ltd. (北海康成（北京）医药科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的5项临床试验, 3篇新闻和2篇文献，疾病领域:神经系统疾病，内分泌 …See details»
Corporate Culture & Career | CANbridge - canbridgepharma.com
CANbridge cultivates a dynamic and collaborative work environment. We offer competitive compensation packages and unparalleled career development opportunities. If you are …See details»
Canada’s complicated drug-approval system needs overhaul, …
3 days ago Doug Clark is calling for reform to Canada’s byzantine drug regulation system. Mr. Clark, former executive director of the Patented Medicine Prices Review Board (PMPRB), in …See details»
| CANbridge
SUZHOU, China, March 13, 2025 - CANbridge Pharmaceuticals Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, …See details»
| CANbridge
Oct 25, 2021 The incidence of BMD is estimated to be 1/18500 - 1/30,000 male births, according to the National Organization for Rare Disease and published peer reviews. The prevalence of …See details»